CREYX | DFREX | CREYX / DFREX | |
Total Expense Ratio | 0.86 | 0.18 | 478% |
Annual Report Gross Expense Ratio | 0.86 | 0.20 | 430% |
Fund Existence | 8 years | 33 years | - |
Gain YTD | -2.100 | 2.767 | -76% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 156M | 6.95B | 2% |
Annual Yield % from dividends | 2.60 | 2.56 | 101% |
Returns for 1 year | 2.47 | 10.70 | 23% |
Returns for 3 years | -15.98 | 5.81 | -275% |
Returns for 5 years | -9.04 | 30.22 | -30% |
Returns for 10 years | N/A | 73.40 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MBGFX | 20.89 | 0.22 | +1.06% |
MassMutual Blue Chip Growth R4 | |||
WCMVX | 18.28 | 0.09 | +0.49% |
WCM Focused International Equity Ins | |||
IJMIX | 16.64 | 0.07 | +0.42% |
VY® JPMorgan Mid Cap Value I | |||
TSHIX | 15.25 | 0.06 | +0.39% |
Transamerica Multi-Asset Income I | |||
PRHSX | 77.35 | 0.27 | +0.35% |
T. Rowe Price Health Sciences |